Tactile Systems Technology, Inc.
Health
Performance
5.7
Risk
Sell
Buy
Curious about the Scores? Learn more.

Tactile Systems Technology, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

13.01.2026
Slowing down. Might be a breather – or a shift.
06.01.2026
Signs of control returning. Still shaky, but not chaos.
10.11.2025
Back on its feet. Fundamentals looking less chaotic.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.

Tactile Systems Technology, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Tactile Systems Technology, Inc. do? Business model and key facts

Get the full picture of Tactile Systems Technology, Inc.: what it builds, where it operates, and how it makes money.

Tactile Systems Technology, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 1037

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

shop
Company facts
Sheri Louise Dodd
CEO
1037
Employees worldwide
shop
Performance
74.33%
Last 12 months
-39.5%
Last 5 years
shop
Growth
$292,98M
Revenue year
$16,96M
Net income
shop
Valuation
$681,01M
Market Cap
24.12
Price/Earnings Ratio

Stocks related to Tactile Systems Technology, Inc.

Selected based on industry alignment and relative market positioning.

PACB
Pacific Biosciences of California, Inc.
2.21
-5.96%
9.2
Sell
Buy
Pacific Biosciences of California, Inc.
CTKB
Cytek Biosciences, Inc.
5.40
-3.91%
7.7
Sell
Buy
Cytek Biosciences, Inc.
SIBN
SI-BONE, Inc.
17.00
-3.30%
6.8
Sell
Buy
SI-BONE, Inc.
SRDX
Surmodics, Inc.
42.98
+0.35%
5.2
Sell
Buy
Surmodics, Inc.
LAB
Standard BioTools Inc.
1.56
-1.27%
7.6
Sell
Buy
Standard BioTools Inc.

Tactile Systems Technology, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.